SINEs of cancer therapy success without ADAR1

被引：2
|
作者：
Zlotorynski, Eytan
机构：
[1] Nature Reviews Molecular Cell Biology,
来源：
NATURE REVIEWS MOLECULAR CELL BIOLOGY | 2020年 / 21卷 / 12期
关键词：
D O I：
10.1038/s41580-020-00310-0
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
RNA editing by ADAR1 destabilizes epigenetic-treatment-induced retrotransposon stem-loops and thus dampens the immune response to the treatment, suggesting that ADAR1 could be a therapeutic target in combination with epigenetic therapy.
引用
收藏
页码：713 / 713
页数：1
相关论文
共 50 条
  • [31] ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis
    Ting Zhang
    Chaoran Yin
    Aleksandr Fedorov
    Liangjun Qiao
    Hongliang Bao
    Nazar Beknazarov
    Shiyu Wang
    Avishekh Gautam
    Riley M. Williams
    Jeremy Chase Crawford
    Suraj Peri
    Vasily Studitsky
    Amer A. Beg
    Paul G. Thomas
    Carl Walkley
    Yan Xu
    Maria Poptsova
    Alan Herbert
    Siddharth Balachandran
    Nature, 2022, 606 : 594 - 602
  • [32] ADAR1: from basic mechanisms to inhibitors
    Rehwinkel, Jan
    Mehdipour, Parinaz
    TRENDS IN CELL BIOLOGY, 2025, 35 (01) : 59 - 73
  • [33] The anti-apoptotic function of ADAR1
    Eytan Zlotorynski
    Nature Reviews Molecular Cell Biology, 2017, 18 : 343 - 343
  • [34] ADAR1 isoform involvement in embryonic lethality
    Steinman, Richard A.
    Wang, Qingde
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (24) : E199 - E199
  • [35] In search of critical dsRNA targets of ADAR1
    Levanon, Erez Y.
    Cohen-Fultheim, Roni
    Eisenberg, Eli
    TRENDS IN GENETICS, 2024, 40 (03) : 250 - 259
  • [36] ADAR1 suppresses the recognition of self dsRNA
    Eytan Zlotorynski
    Nature Reviews Molecular Cell Biology, 2015, 16 (9) : 518 - 518
  • [37] Discovery of small molecule inhibitors of ADAR1
    Buker, Shane M.
    Blakemore, Stephen J.
    Boriack-Sjodin, P. Ann
    Collins, Cindy
    Copeland, Robert A.
    Duncan, Kenneth W.
    Ericsson, Anna
    Garadino, Alexandra
    Greene-Colozzi, April
    Leger, Nathalie
    Lockbaum, Gordon
    Raman, Anugraha
    Ribich, Scott
    Sickmier, Allen
    Sparling, Brian S.
    Wu, Jie
    Silver, Serena
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [38] ADAR1 in lenalidomide resistance: still immunomodulation?
    Gooding, Sarah
    BLOOD, 2025, 145 (11) : 1104 - 1106
  • [39] Discovery of a Novel Covalent ADAR1 Inhibitor
    Wang, C.
    McKinney, A.
    Marcolino, M.
    Quanrud, G.
    Dong, I.
    Chen, A.
    Deng, N.
    Guo, S.
    Jansa, P.
    Yuan, I.
    Cao, P.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S164 - S164
  • [40] ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis
    Zhang, Ting
    Yin, Chaoran
    Fedorov, Aleksandr
    Qiao, Liangjun
    Bao, Hongliang
    Beknazarov, Nazar
    Wang, Shiyu
    Gautam, Avishekh
    Williams, Riley M.
    Crawford, Jeremy Chase
    Peri, Suraj
    Studitsky, Vasily
    Beg, Amer A.
    Thomas, Paul G.
    Walkley, Carl
    Xu, Yan
    Poptsova, Maria
    Herbert, Alan
    Balachandran, Siddharth
    NATURE, 2022, 606 (7914) : 594 - +
12345